Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus

• Main Authors: Tetsuo Hayakawa (Author), Ken-Ichiro Kato (Author), Shinji Kobuchi (Author), Kaede Kataoka (Author), Toshiyuki Sakaeda (Author)
• Formato: Livro
• Publicado em: MDPI AG, 2022-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

This study was conducted to evaluate the long-term plasma concentration profiles of dapagliflozin and its effects on the glycated hemoglobin (HbA1c) level, body weight, and estimated glomerular filtration rate (eGFR) in 72 Japanese outpatients with type 2 diabetes mellitus (T2DM) receiving metformin...